Reference
Schoenfeld AJ, et al. Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer. Clinical Cancer Research 26: 2654-2663, No. 11, Jun 2020. Available from: URL: http://doi.org/10.1158/1078-0432.CCR-19-3563
Rights and permissions
About this article
Cite this article
Alectinib/osimertinib. Reactions Weekly 1818, 19 (2020). https://doi.org/10.1007/s40278-020-82299-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-82299-2